MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2022 International Congress

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: a real-life study

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, H. Couckuyt, M. van Zandijcke (Bruges & Ghent, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles (IC) into…
  • 2022 International Congress

    Botulinum neurotoxin simulation workshop: Impact on resident satisfaction and knowledge

    C. Selvadurai, E. Cournean, N. Prakash, B. Rodrigues (Farmington, USA)

    Objective: To assess resident satisfaction and knowledge after a hands-on Botulinum toxin (BoNT) simulation workshop (SW). Background: Despite having an application for BoNT in almost…
  • 2022 International Congress

    Limb myorhythmia treated with chemodenervation: A case report

    N. Saez Calveras, M. Bryarly, M. Salinas (Dallas, USA)

    Objective: To describe the case of a patient with limb myorhythmia successfully treated with bolutinum toxin injections. Background: Myorhythmia is a rare condition characterized by…
  • 2022 International Congress

    Hypersensitive reaction to botulinum toxin type A following Covid19 mRNA vaccination

    VL. Livneh, L. Barsky, H. Shabtai, A. Ezra, T. Gurevich (Tel Aviv, Israel)

    Objective: two cases of hypersensitivity reactions to botulinum toxin type A (BTA) following mRNA based COVID-19 vaccine Background: Botulinum toxin type A is  widely used…
  • MDS Virtual Congress 2021

    Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders

    S. Berweck, H. Kim, M. Banach, A. Hanschmann, M. Althaus, M. Bonikowski (Vogtareuth, Germany)

    Objective: The SIPEXI (Sialorrhea Pediatric Xeomin Investigation) study investigated efficacy and safety of intraglandular incobotulinumtoxinA (incoBoNT/A) injections in children/adolescents with sialorrhea associated with neurological disorders…
  • MDS Virtual Congress 2021

    Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

    C. Borrue, C. Jimeno (Madrid, Spain)

    Objective: Investigate the safety and efficacy of botulinum toxin type A in Parkinson´s disease and parkinsonism patients affected by sialorrhea Background: Sialorrhea is excessive salivation…
  • MDS Virtual Congress 2020

    Painful Legs and Moving Toes (PLMT): A Case Series

    N. Labaure, I. Amorin, A. Lescano, G. Morando (Montevideo, Uruguay)

    Objective: Describe and characterize our PLMT patients in terms of clinical presentation, neurophysiology, imaging, associated conditions and response to treatment. Background: First described by Spillane…
  • MDS Virtual Congress 2020

    Ultrasound-guided treatment of action tremor of the upper limb with botulinum toxin

    M.C Costa, P. Pita-Lobo, C. Figueiredo, L. Rebordão, A. Cadete (Amadora, Portugal)

    Objective: To assess the functional benefit of ultrasound-guided treatment with botulinum toxin type A in patients with action tremor of the upper limb. Background: Action…
  • MDS Virtual Congress 2020

    Botulinum Toxin Injections for Upper Limb Dystonia with Tremor

    R. Rajan, R. Anandapadmanabhan, A. Saini, V.Y Venugopalan, A. Gupta, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To study the effect of BoNT injections on tremor in patients with upper limb dystonia with hand tremor. Background: Tremor is a common accompaniment…
  • MDS Virtual Congress 2020

    Use of Botulinum Toxin: Experience in a Cohort of Essential Tremor Patients

    C. Shah, F. Jamal, A. Sarwar, G. Jackson (Houston, TX, USA)

    Objective: To review the treatment characteristics of botulinum toxin in medically refractory essential tremor (ET). Background: Treatment of medically refractory essential tremor has remained challenging…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley